• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

麻风病患者中补体介导的免疫复合物溶解减少。

Reduced complement-mediated immune complex solubilization in leprosy patients.

作者信息

Ramanathan V D, Sharma P, Ramu G, Sengupta U

出版信息

Clin Exp Immunol. 1985 Jun;60(3):553-8.

PMID:3874729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1577209/
Abstract

The ability of sera from leprosy patients to solubilize immune precipitates in vitro through the complement system was studied. The solubilizing capacity of sera from patients who did not have any reactions during 2 years or more after starting chemotherapy was comparable with that of normal laboratory volunteers. On the other hand, sera from borderline tuberculoid and lepromatous leprosy patients in reaction had markedly decreased levels of solubilization. Their total and the alternative pathway haemolytic levels did not show a corresponding decrease. Although the circulating immune complexes and serum C3d of these patients came down after the subsidence of reaction, their solubilization remained consistently low during a 3 month follow-up period.

摘要

研究了麻风病人血清通过补体系统在体外溶解免疫沉淀物的能力。开始化疗后两年或更长时间内无任何反应的病人血清的溶解能力与正常实验室志愿者的相当。另一方面,处于反应期的界线类偏结核型和瘤型麻风病人的血清溶解水平明显降低。他们的总溶血水平和替代途径溶血水平并未相应降低。虽然这些病人的循环免疫复合物和血清C3d在反应消退后下降,但在3个月的随访期内其溶解能力一直很低。

相似文献

1
Reduced complement-mediated immune complex solubilization in leprosy patients.麻风病患者中补体介导的免疫复合物溶解减少。
Clin Exp Immunol. 1985 Jun;60(3):553-8.
2
Solubilization of preformed immune complexes in sera of patients with type 1 and type 2 lepra reactions.1型和2型麻风反应患者血清中预先形成的免疫复合物的溶解
Int J Lepr Other Mycobact Dis. 1988 Dec;56(4):559-65.
3
Persistent reduced solubilization of immune complexes in lepromatous leprosy patients with reactions.麻风瘤型麻风反应患者免疫复合物的持续溶解性降低。
Int J Lepr Other Mycobact Dis. 1991 Mar;59(1):5-11.
4
A sequential study of circulating immune complexes, complement and immunoglobulins in borderline tuberculoid leprosy patients with and without reactions.
Indian J Lepr. 1998 Apr-Jun;70(2):153-60.
5
Activation of complement by circulating immune complexes isolated from leprosy patients.
Int J Lepr Other Mycobact Dis. 1990 Mar;58(1):31-8.
6
Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.补体激活以及在原发性混合性冷球蛋白血症中溶解免疫复合物或阻止其形成的能力受损。
Diagn Immunol. 1983;1(4):315-23.
7
[Serum complement levels in patients with rheumatoid arthritis and vasculitis].[类风湿关节炎和血管炎患者的血清补体水平]
Fukuoka Igaku Zasshi. 1989 Oct;80(10):456-66.
8
Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.免疫沉淀物溶解过程中C3与抗原-抗体复合物的相互作用。
J Immunol. 1984 May;132(5):2531-7.
9
Formation of soluble immune complexes by complement in sera of patients with various hypocomplementemic states. Difference between inhibition of immune precipitation and solubilization.补体在各种低补体血症状态患者血清中形成可溶性免疫复合物。免疫沉淀抑制与溶解之间的差异。
J Clin Invest. 1985 Dec;76(6):2127-33. doi: 10.1172/JCI112217.
10
Circulating immune complexes associated with decreased complement-mediated inhibition of immune precipitation in sera from patients with bacterial endocarditis.循环免疫复合物与细菌性心内膜炎患者血清中补体介导的免疫沉淀抑制作用降低有关。
Clin Exp Immunol. 1986 Feb;63(2):359-66.

引用本文的文献

1
A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum.结节性麻风红斑免疫学研究的系统评价
Front Immunol. 2017 Mar 13;8:233. doi: 10.3389/fimmu.2017.00233. eCollection 2017.
2
Defective solubilization of immune complexes and activation of the complement system in patients with pulmonary tuberculosis.肺结核患者免疫复合物的溶解缺陷和补体系统的激活。
J Clin Immunol. 2009 Sep;29(5):674-80. doi: 10.1007/s10875-009-9301-0. Epub 2009 May 27.

本文引用的文献

1
Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis.系统性红斑狼疮、肾炎或血管炎患者的补体介导溶解作用。
Clin Exp Immunol. 1981 Dec;46(3):557-64.
2
Activation of the alternative pathway of complement by mycobacteria and cord factor.分枝杆菌与索状因子对补体替代途径的激活作用。
Infect Immun. 1980 Jul;29(1):30-5. doi: 10.1128/iai.29.1.30-35.1980.
3
Solubilization of antigen-antibody complexes: a new function of complement as a regulator of immune reactions.抗原-抗体复合物的溶解:补体作为免疫反应调节因子的新功能。
Prog Allergy. 1980;27:134-66.
4
Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.系统性红斑狼疮患者血清中补体介导的免疫复合物溶解能力降低以及存在未完全溶解的免疫复合物。
Clin Exp Immunol. 1983 Nov;54(2):439-47.
5
Isolation and analysis of circulating immune complexes in leprosy.
Clin Immunol Immunopathol. 1984 Sep;32(3):261-8. doi: 10.1016/0090-1229(84)90270-8.
6
Dapsone and complement.氨苯砜与补体。
Lancet. 1981 Aug 15;2(8242):368-9. doi: 10.1016/s0140-6736(81)90690-5.
7
Classification of leprosy according to immunity. A five-group system.根据免疫情况对麻风病进行分类。一种五组分类系统。
Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255-73.
8
Immune complexes in glomeruli of patients with leprosy.麻风病患者肾小球中的免疫复合物。
Lepr Rev. 1971 Dec;42(4):282-9. doi: 10.5935/0305-7518.19710034.
9
Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon.麻风结节性红斑:阿瑟斯现象的一种临床表现。
Lancet. 1969 Nov 1;2(7627):933-5. doi: 10.1016/s0140-6736(69)90592-3.
10
Activation of the alternate pathway of human complements by rabbit cells.兔细胞对人补体替代途径的激活。
J Immunol. 1974 Jul;113(1):348-58.